ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Identifying a novel target for cancer immunotherapy – Medical Xpress

Continue reading

2017-04-12 Michael Zand NEWS

Study suggests why an immunotherapy drug works in some melanoma patients but not in others – Cancer Research UK

Identifying a novel target for cancer immunotherapy
Medical Xpress
Immunotherapy is a type of cancer treatment that stimulates the patient’s own immune system to attack cancer cells. One immunotherapy approach involves targeting a group of proteins, called immune checkpoints, that normally prevents the immune system …

Continue reading

2017-04-12 Michael Zand NEWS

Neuralstem Expands Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal Injury – GlobeNewswire (press release)

Neuralstem Expands Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal InjuryGlobeNewswire (press release)GERMANTOWN, Md., April 12, 2017 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development … Continue reading

2017-04-12 Michael Zand NEWS

Neuralstem Expands Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal Injury – GlobeNewswire (press release)

Neuralstem Expands Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal InjuryGlobeNewswire (press release)GERMANTOWN, Md., April 12, 2017 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development … Continue reading

2017-04-12 Michael Zand NEWS

Synthetic Biology Building a custom eukaryotic genome de novo – Nature.com

Nature.comSynthetic Biology Building a custom eukaryotic genome de novoNature.comThe Synthetic Yeast Project (Sc2.0) aims to create the first synthetic eukaryotic genome. It is based on synthesizing, from scratch, a reworked Saccharomyces cerevisiae ge… Continue reading

2017-04-12 Michael Zand NEWS

Synthetic Biology Building a custom eukaryotic genome de novo – Nature.com

Nature.comSynthetic Biology Building a custom eukaryotic genome de novoNature.comThe Synthetic Yeast Project (Sc2.0) aims to create the first synthetic eukaryotic genome. It is based on synthesizing, from scratch, a reworked Saccharomyces cerevisiae ge… Continue reading

2017-04-12 Michael Zand NEWS

Building a custom eukaryotic genome de novo – Nature.com

Nature.comBuilding a custom eukaryotic genome de novoNature.comThe Synthetic Yeast Project (Sc2.0) aims to create the first synthetic eukaryotic genome. It is based on synthesizing, from scratch, a reworked Saccharomyces cerevisiae genome that is optim… Continue reading

2017-04-12 Michael Zand NEWS

Stem cell transplant : One year later, donor and recipient meet – The Indian Express


Cancer Research UK

Study suggests why an immunotherapy drug works in some melanoma patients but not in others
Cancer Research UK
Some immunotherapy drugs, such as pembrolizumab (Keytruda), work by blocking molecules on the surface of immune cells or tumour cells that act as a set of ‘brakes’ on the immune system. Blocking these molecules, including PD-1 which pembrolizumab …

Continue reading

2017-04-12 Michael Zand NEWS
  • 1
  • …
  • 1,856
  • 1,857
  • 1,858
  • 1,859
  • 1,860
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

The Indian Express

Stem cell transplant : One year later, donor and recipient meet
The Indian Express
“Gauri was being treated at a Sector 32 hospital in Chandigarh and later we visited Dr Joseph John, Prof and head of Hematology department CMC as we were keen for a stem cell transplant. In early 2014, we found a donor and later in October 15, 2014, …

and more »